lar reabsorption, renin secretion, and tubuloglomerular feedback (TGF) responses (15, (36) (37) (38) . TGF is a vasoconstrictive response of the afferent arteriole that reduces the glomerular capillary pressure and the singlenephron glomerular filtration rate (SNGFR) during reabsorption of NaCl by the macula densa segment (7) . This vasoconstrictive response is enhanced in the spontaneously hypertensive rat (SHR) model of hypertension and may contribute to renal mechanisms for the development of hypertension (9) . A neuronal or type I isoform of nitric oxide synthase (nNOS) is heavily expressed in macula densa cells (35, 39) and an endothelial or type III isoform of NOS (eNOS) is expressed in microvascular and glomerular capillary endothelium (33, 35) . Pharmacological studies have shown that nNOS in macula densa cells is activated during NaCl reabsorption. The ensuing generation of NO offsets the primary vasoconstrictive effects of TGF on the afferent arteriole and diminishes further NaCl reabsorption by the macula densa cells (39) . The overactive TGF in the genetic SHR model of hypertension has been ascribed to a diminished role for macula densa NO in buffering the vasoconstrictive response (34, 36) . Thus SHR has a diminished or absent TGF response to local inhibition of NOS in the juxtaglomerular apparatus (JGA) with nitro-L-arginine (NLA) (34) or nNOS with 7-nitroindazole (7-NI) (36) .
The cause for the diminished blunting of TGF by NO in nephrons of SHR is presently unexplained. The mRNA and protein expression for nNOS and eNOS in the JGA of SHR is enhanced compared with control Wistar-Kyoto rats (WKY) (36) . TGF is unresponsive to microperfusion of the NOS substrate L-arginine or the NOS cofactor tetrahydrobiopterin or its precursor sepiapterin into the macula densa segment (36) . Therefore, there does not appear to be a defect in the expression of constitutive NOS isoforms, or in the delivery of NOS substrate or cofactors to the JGA to explain the defective function of NO in the SHR.
The aorta of SHR has an impaired endotheliumderived relaxing factor (EDRF) response. This is ascribed to an endothelium-derived contraction factor (EDCF) that can inactivate NO (18) . The precise identity of EDCF remains unclear, but its generation or action depends on oxygen radicals (O 2 Ϫ ). O 2 Ϫ interacts with NO to yield peroxynitrate (ONOO Ϫ ), which effectively reduces the biological half-life of NO. Peroxynitrate itself can interact with tyrosine residues to form nitrotyrosine. In the 2-kidney, 1-clipped rat model of hypertension, nitrotyrosine immunoreactive expression is prominent in the extraglomerular mesangium and interstitium between the macula densa cells and the afferent arteriole (5) . Therefore, the JGA appears to be a prominent site for generation of O 2 Ϫ that could inactivate NO formed in the macula densa.
We tested the hypothesis that a defect in NO function in the JGA of the SHR despite ongoing NO generation could be ascribed to enhanced degradation of NO via interaction with O 2 Ϫ . Nitrotyrosine immunoreactivity was used to assess the net interaction between renal NO and O 2 Ϫ . TGF responses to microperfusion of 7-NI were used to assess the role of nNOS in the macula densa. The response to NO was assessed by microperfusion of S-nitroso-N-acetyl-penicillamine (SNAP), which is an NO donor compound. The nitroxide, tempol (2,2,6,6-tetramethyl-1-piperidinyloxy, 8-hydroxy form), is a low-molecular-weight membrane-permeant, metalindependent, stable, superoxide dismutase (SOD) mimetic that is used as an O 2 Ϫ spin trap. Tempol was microperfused into the vasculature surrounding the JGA to assess the role of O 2 Ϫ .
METHODS
Studies were undertaken on male SHR and WKY weighing 241 Ϯ 11 g and maintained on a standard rat chow (Purina, St. Louis, MO) with a sodium content of 0.3 g/100 g. They were allowed free access to food and water until the day of study.
Series 1: Western analysis of nitrotyrosine abundance in renal cortex. These studies were designed to test the hypothesis that there is enhanced nitrotyrosine immunoreactivity in the kidney of the SHR. Under pentobarbital anesthesia (100 mg/kg ip), the abdomen was opened, and the aorta was cannulated to allow flushing of the kidneys with ice-cold buffered saline at pH 7.4. The kidneys were removed and stored at Ϫ80°C until analyzed. The cortex was homogenized in a glass tissue homogenizer (Iwaki, Chiba, Japan) in 1 ml buffer containing 20 mM Tris, pH 7.2, 0.5 mM EGTA, 1 mM leupeptin, 1 mM DTT, and 0.1 mM phenylmethylsulfonyl fluoride. Homogenates were sonicated three times for 40 s and centrifuged at 12,000 g for 15 min. The supernatants were diluted in an equivalent volume of SDS buffer [0.5 M Tris-HCl pH 6.8, 20% (vol/vol) glycerol, 4.6% (wt/vol) SDS] and boiled for 5 min. Protein amount in the renal cortex homogenate was measured by the Bradford method (Bio-Rad, Richmond, CA). Samples containing 150 µg protein were applied to an 8% SDS gel, and proteins were separated by SDS-PAGE and electroblotted to a nitrocellulose membrane (Pierce, Rockford, IL). The membrane was stained by Ponceau solution to verify the protein transfer to the membrane was complete. The nitrocellulose membranes were incubated with 5% nonfat dry milk in Tris-buffered saline with 0.1% Tween 20 (TBST) for 1 h, followed by overnight incubation with a monoclonal antibody for nitrotyrosine (Upstate Technology, Lake Placid, NY) in a 1:200 dilution. After rinsing in TBST, membranes were incubated for 2 h with an horseradish peroxidase (HRP)-conjugated secondary antibody against mouse IgG at a 1:1,000 dilution. HRP labeling was detected by diaminobenzidine with 0.3% H 2 O 2 .
Series 2: Maximal TGF responses to luminal microperfusion of the nNOS inhibitor, 7-NI, and effects of efferent arteriolar microperfusion of tempol. These experiments were designed to test the hypothesis that the enhanced TGF responses of SHR nephrons could be ascribed to a blunted generation of NO by nNOS in the macula densa because of enhanced degradation by O 2 Ϫ . Groups of SHR and agematched WKY rats were prepared for in vivo micropuncture, microperfusion, and TGF studies as described in detail previously. In brief, animals weighing 210-275 g were anesthetized with thiobarbital (Inactin, 100 mg/kg ip; Research Biochemicals International, Natick, MA). A catheter was placed in a jugular vein for fluid infusion and in a femoral artery for recording of mean arterial pressure (MAP) from the electrically damped output of a pressure transducer (Statham). A tracheotomy tube was inserted and the animals were allowed to breathe spontaneously. The left kidney was exposed by a flank incision, cleaned of connective tissue, and stabilized in a Lucite cup. This kidney was bathed in 0.154 M NaCl maintained at 37°C. After completion of surgery, rats were infused with a solution of 0.154 M NaCl and 1% albumin at 1.5 ml/h to maintain a euvolemic state. Micropuncture studies were begun after 60 min for stabilization.
For orthograde microperfusion of the loop of Henle (LH), a micropipette (8 µm OD) containing artificial tubular fluid (ATF) stained with FD&C green dye was inserted into a late proximal tubule. Injections of the colored ATF identified the nephron and the direction of flow. An immobile stained bone wax block was inserted into this micropuncture site via a micropipette (10-15 µm) connected to a hydraulic drive (Trent Wells, San Diego, CA) to halt tubular fluid flow. A perfusion micropipette (6-8 µm) containing ATF with test compounds or vehicle was inserted into the proximal tubule downstream from the wax block and connected to a nanoliter perfusion pump (WPI, Sarasota, FL). A pressure micropipette (1-2 µm) was inserted into the proximal tubule upstream from the wax block to measure the proximal stop-flow pressure (P SF ). The pressure was recorded by a servo-null instrument (Instruments for Physiology, La Jolla, CA). Changes in P SF are an index of changes in glomerular capillary hydraulic pressure. Measurements of P SF were made in each nephron during zero loop perfusion and during perfusion with ATF at 40 nl/min, which produces a maximal TGF response, defined as the difference between P SF values recorded during perfusion of the LH with ATF at 0 and 40 nl/min.
The maximal TGF responses were determined in eight nephrons from SHR (n ϭ 5) and eight nephrons from WKY rats (n ϭ5) during perfusion of the LH with ATF ϩ vehicle and contrasted with ATF ϩ 7-NI (10 Ϫ4 M). In previous studies, this was found to be a maximally effective dose.
Ten nephrons from SHR (n ϭ 5) and 10 from WKY rats (n ϭ 5) were prepared for studies of microperfusion into the peritubular capillaries (PTC) via the efferent arteriole (EA) of tempol (10 Ϫ4 M) (30) dissolved in artificial plasma (AP) (36) containing FD&C green dye. The last proximal convolution of a nephron that was in the perfused field was punctured, and a wax block was placed upstream. A micropipette (8-10 µm) was inserted into the EA adjacent to the test nephron. The LH was perfused orthogradely with ATF at zero and 40 nl/min. This represents the maximal TGF response. Preliminary studies indicated that a dose of tempol of 10 Ϫ4 M was maximally effective, and the response was fully reversible. Therefore, this dose was used for these studies. After the basal measurement of TGF with LH perfusion of ATF, the EA was perfused at 15 nl/min with AP ϩ tempol. After 5 min with the EA microperfusion continuing, the TGF was again tested by perfusion of ATF at 0 and 40 nl/min into the LH. We have shown that PTC perfusion with AP at 15-20 nl/min does not perturb TGF responses. Only nephrons for which the surrounding interstitium was tinted with the PTC perfusion of stained tempol solution were included in the study.
A further group of six WKY and nine SHR were used to test the hypothesis that the failure of TGF responses of SHR nephrons to enhance with local microperfusion of 7-NI is due to degradation of NO by O 2 Ϫ in the JGA. The maximum TGF responses of SHR and WKY to orthograde microperfusion of ATF ϩ vehicle were compared with ATF ϩ 7-NI (10 Ϫ4 M) during a 5-min microperfusion of tempol (10 Ϫ4 M) in AP at 15 nl/min into the EA.
Series 3: Dose-response relationship of TGF to microperfusion of NO donor compound into JGA: effects of tempol. The aim of this series was to test the hypothesis that graded doses of NO, delivered directly into the JGA, have a reduced biologic activity in SHR nephrons that can be corrected by a membrane-permeant SOD mimetic. Rats were prepared as in series 2 above. The maximum TGF responses of SHR (n ϭ 16 nephrons) and WKY (n ϭ 18 nephrons) to orthograde microperfusion of ATF ϩ SNAP (10 Ϫ7 M, 10 Ϫ6 M, 10 Ϫ5 M, and 10 Ϫ4 M) were studied in the basal state, and during EA microperfusion of tempol (10 Ϫ4 M).
Drugs. Values are means Ϯ SE. SHR, spontaneously hypertensive rat; WKY, Wistar-Kyoto rat; MAP, mean arterial pressure; GFR, glomerular filtration rate; HR, heart rate; P SF , stop-flow pressure; LH, loop of Henle; NS, not significant. Tables  1-4 . However, the basal TGF responses were greater in SHR than WKY. Therefore, to adjust for baseline differences, the results are shown graphically as percentage changes in TGF from baseline values, according to the criteria of Kaiser (13) .
RESULTS
For series 1, immunoreactive bands corresponding to nitrotyrosine were seen at 47, 58, 74, 89, and 102 kDa in proteins extracted from rat renal cortex. These bands were consistently stronger in kidneys from SHR than WKY (Fig. 1) . Densitometric analysis of bands at 58 kDa confirmed that the amount of nitrotyrosine immunoreactive protein expression was significantly greater in SHR than WKY kidneys (Fig. 2) . Table 1 presents baseline data for rats used in the functional studies of series 2. Compared with WKY, SHR had similar body and kidney weights but had consistently higher levels of MAP and slightly greater heart rates (HR). TGF parameters showed higher values for P SF in SHR nephrons in the absence of loop perfusion and a greater maximal TGF response, as assessed from the difference between P SF during perfusion at 0 and 40 nl/min. The maximum response in SHR averaged 123 Ϯ 10% of the mean value in WKY.
The maximum TGF responses were contrasted in SHR and WKY nephrons during microperfusion of 7-NI orthograde into the LH. As shown in Table 2 , the maximum TGF responses again were greater in SHR than WKY during perfusion of ATF ϩ vehicle. The addition of 7-NI increased maximal TGF responses consistently in WKY by an average of 30 Ϯ 4% but had no significant effects on TGF responses of SHR (Fig.  3A) .
Microperfusion of tempol into the EA blunted maximum TGF responses significantly (P Ͻ 0.01) in both WKY and SHR nephrons (Table 3) . However, as shown in Fig. 3B , the percentage of blunting of TGF in nephrons of SHR was nearly double that in WKY.
During microperfusion of tempol into the EA, orthograde loop perfusion of 7-NI increased TGF responses in WKY rat nephrons by 28 Ϯ 5%; this is similar to the 30 Ϯ 4% increase seen with 7-NI in WKY in the absence of tempol (Table 2 ). However, during EA microperfusion of tempol in SHR nephron, orthograde loop perfusion of 7-NI increased TGF by 32 Ϯ 5% (Fig. 3C) . This is significantly (P Ͻ 0.001) more than the 5 Ϯ 3% (not significant) change seen with 7-NI in SHR in the absence of tempol. During tempol, the changes in maximal TGF with 7-NI become quite similar in WKY and SHR ( Fig. 3C ; Table 4 ).
For series 3, log-dose response relationships for blunting of maximal TGF responses during orthograde luminal microperfusions of SNAP into the LH are shown in the basal state (Fig. 4A) or during EA microperfusion of tempol (Fig. 4B) . Before tempol, SNAP at 10 Ϫ7 M was a subthreshold dose in both WKY and SHR, as indicated by nonsignificant changes in TGF responses. SNAP at 10 Ϫ6 M blunted TGF significantly (P Ͻ 0.05) in WKY but not in SHR nephrons. SNAP at 10 Ϫ5 M blunted TGF significantly (P Ͻ 0.05) more in WKY than in SHR nephrons. The responses to a full dose of SNAP at 10 Ϫ4 M were similar in the two strains. As shown in Fig.   Fig. 3 . Fractional increases (means Ϯ SE) in tubuloglomerular feedback (TGF) responses to loop of Henle (LH) perfusion of 7-nitroindazole (7-NI, 10 Ϫ4 M) in WKY (open bar, n ϭ 8) and SHR (hatched bar, n ϭ 8) (A); efferent arteriole (EA) perfusion of tempol (10 Ϫ4 M) in WKY (n ϭ 10) and SHR (n ϭ 10) (B); and LH perfusion of 7-NI during simultaneous EA perfusion of tempol (10 Ϫ4 M) in WKY (n ϭ 12) and SHR (n ϭ 16) (C). TGF responses are defined as changes in proximal stop-flow pressure (P SF ) at 0 LH perfusion and at 40 nl/min. 4B, in the presence of tempol microperfused into the EA, 10 Ϫ7 M SNAP became an effective dose in both SHR and WKY nephrons. Tempol enhanced the response to SNAP at each dose, but this effect was more pronounced in SHR, whose responses became strictly comparable to those in WKY throughout the dose range tested. These data demonstrate that SHR have impaired sensitivity to the NO donor compound that is corrected by local microperfusion of tempol.
DISCUSSION
The main new findings of this study are that the kidney of the SHR has increased immunoreactive expression of nitrotyrosine. The exaggerated TGF responses of SHR nephrons are blunted by a membranepermeant SOD mimetic, tempol. There is a diminished sensitivity of TGF in SHR nephrons to local microperfusion of the NO donor compound SNAP. Microperfusion of tempol restores a TGF response to blockade of nNOS with 7-NI in SHR and restores a normal dose-dependent blunting of TGF by SNAP. These data are consistent with the hypothesis that an increase in O 2 Ϫ in the JGA of the SHR decreases the bioactivity of locally formed NO and thereby increases the TGF response. NO signaling in the JGA is restored to normal by local microperfusion of tempol.
Reports of an enhanced TGF response in SHR nephrons (9, 34, 36) are confirmed in this study. This increased TGF response was not corrected by shortterm normalization of the renal perfusion pressure with a supra-aortic renal clamp (9, 36) . We propose this is due to loss of buffering of TGF by JGA-derived NO, since there is loss of the normal enhancement of TGF by microperfusion of NOS inhibitors into the macula densa area of the JGA. The present studies show further that this defect is likely due to NO activity in the macula densa, since SHR failed to respond to 7-NI microperfused into the lumen of the macula densa, whereas robust and consistent responses were seen in the control WKY, as in previous studies of normal rats. 7-NI is more selective for nNOS than methyl-or nitro-arginine-based inhibitors. When infused into experimental animals, it inhibits nNOS in brain within 30 min without altering the blood pressure or the response to the endothelium-dependent agonist, ACh (4, 19, 40) . Prolonged administration of 7-NI to rats enhances TGF and reduces GFR without blocking ACh-induced vasodilation of the afferent arteriole (23) . Thorup and Persson (34) have shown that microperfusion of NLA into the tubular lumen near the macula densa enhances TGF responses more in WKY than SHR. Our results with 7-NI suggest that nNOS is located in the macula densa. This could be implicated in the pathogenesis of hypertension since normal rats infused with 7-NI develop hypertension that is preceded by enhancement of TGF and reduced renal function (23).
Mitchell et al. (21) have shown that tempol acts as a membrane-permeant SOD mimetic. Tempol does not alter hydrogen peroxide concentration in brain (28) and does not bind nor generate NO directly (29) . It is a fully validated spin-trap for O 2 Ϫ (22). Tempol protects cells and tissues against oxidative stress (20, 29) . Therefore, we selected this nitroxide to probe the functional role of O 2 Ϫ in these studies. The cause for the apparent loss of NO function in the macula densa of SHR has been elusive. It cannot be ascribed to a general failure of SHR renal arterioles to constrict normally, since the TGF response of the SHR is overactive, and renal arteriolar vasoconstrictor responses to many agonists such as ANG II or U-46,619 are enhanced (8) . Nor can it be attributed to a defect in expression of constitutive NOS isoforms in the JGA, since our recent studies have shown that the abun- Values are means Ϯ SE. (36) . Nor can it be due to a failure to supply the NOS substrate, L-arginine, or the NOS cofactor, tetrahydrobiopterin, to the JGA, since microperfusion of these agents into the macula densa does not modify TGF, or its response to 7-NI, in the SHR (36) . Therefore, the present studies were undertaken to assess a contrasting hypothesis that defective NO function in the JGA of the SHR is due rather to a failure to respond to NO, because of enhanced degradation. It has long been known that the short biological half-life and restricted diffusion distance of NO in blood vessel walls are due to rapid and irreversible inactivation by oxygen radicals that oxidize NO initially to peroxynitrite (11, 27) . Peroxynitrite can nitrosylate tyrosine epitopes leading to nitrotyrosine formation whose expression provides an index of oxidative stress (32) . A consistent and strong band of immunoreactive nitrotyrosine was detected in proteins extracted from the renal cortex. The nature of this predominant nitrated tyrosine antigen is unclear. Nevertheless, its expression was enhanced consistently in the renal cortex of SHR, compared with WKY. This finding extends our previous observation that isoprostane excretion is increased in SHR and that this increase can be normalized by a 2-wk administration of tempol (30) . Isoprostanes are formed by nonenzymic interactions between O 2 Ϫ and arachidonate. These findings at the level of the kidney and whole circulation complement extensive previous studies of isolated vessels of SHR that have shown an enhanced agonist-induced release of EDCF that accounts for a diminished EDRF activity (3) . EDCF depends upon oxygen radicals (1), cyclooxygenase (17) , and thromboxane-PGH 2 (TP) receptors (2) . In a recent study, Brannstrom et al. (6) have shown that much of the exaggerated TGF response in SHR is dependent on activation of TP receptors. This may relate to increased O 2 Ϫ activity, through formation of isoprostanes that act on TP receptors (26) . An interaction of O 2 Ϫ with both NO and arachidonate could represent an additional level of regulation of TGF during oxidant stress.
Previous studies of EDCF and O 2 Ϫ have shown that they are important mediators of large vessel responses in hypertension and atherosclerosis (1) . The present studies are the first to demonstrate a role for O 2 Ϫ in the JGA in regulation of afferent arteriolar tone via interaction with NO.
Evidence that oxidant stress and O 2 Ϫ account for exaggerated preglomerular vasoconstriction, enhanced TGF, and a diminished functional role for NO in the JGA of the SHR were derived from two sets of experiments.
First, the blunting of TGF by the NO donor compound, SNAP, showed a diminished sensitivity but a preserved maximal responsiveness. The preserved responsiveness suggests that NO responsive elements in the SHR afferent arteriole were intact. The diminished sensitivity to SNAP in SHR is consistent with enhanced NO degradation via O 2 Ϫ . This conclusion was strengthened by the observation that microperfusion of tempol via the EA normalized the sensitivity to SNAP in the SHR. Our interpretation is that the SOD mimetic, tempol, metabolizes O 2 Ϫ to H 2 O 2 and O 2 , which do not directly interact with NO. Therefore, tempol enhances the effectiveness of physiologically relevant concentrations of NO by diminishing its rapid degradation. Since this effect of tempol is more pronounced in SHR than WKY, it implies that O 2 Ϫ -induced NO degradation similarly is more pronounced in SHR than WKY nephrons.
Second, we observed that nephrons of SHR were approximately twice as responsive as WKY to microperfusion of tempol, as shown by twice as great a fractional blunting of TGF in the hypertensive model (Fig. 3B) . If this effect of tempol is due to activation of a latent NO-dependent vasodilator mechanism that offsets TGF responses, we argued that tempol should restore a normal response to nNOS inhibition in the SHR. Indeed, microperfusion of tempol into the EA normalized the response to microperfusion of 7-NI into the macula densa of the SHR (Fig. 3C) . We conclude that the failure of the JGA L-arginine-NO pathway to function in the SHR can be ascribed to excessive NO degradation by O 2 Ϫ , rather than to an intrinsic failure in the system to generate NO in the macula densa or to respond to NO in the vessel wall.
The present studies leave unanswered the source of O 2 Ϫ generated in the JGA. Nitrotyrosine immunoreactivity in the 2-kidney, 1-clipped Goldblatt hypertensive rat model is expressed densely in the interstitium and the extraglomerular mesangial cells between the macula densa and the afferent arteriole (5). The interstitium and extraglomerular mesangium may form a barrier that isolates NO generated in the macula densa from targets in the afferent arteriole. NADPH oxidase is the predominant source of O 2 Ϫ generation in the vessel wall of hypertensive models (25) . It is expressed strongly in adventitial fibroblasts (24) and mesangial cells (12) . Mesangial cell NADPH oxidase is stimulated to generate O 2 Ϫ by ANG II acting on AT 1 receptors (12). Therefore, NADPH oxidase could be the predominant source of O 2 Ϫ generation in the JGA. Since this source of O 2 Ϫ is strongly dependent on AT 1 receptor activity, the level of oxidative stress in the SHR may vary with age. We have tested 9-to 10-wk-old rats. This is a time when hypertension is fully achieved and an exaggerated TGF is present. Although enhanced TGF is more often seen in young SHR (6, 9, 11), decreased renal blood flow and GFR have been observed in mature SHR (10, 14, 34) . The level of ANG II also varies in the SHR. Most studies agree, however, that blockade of ANG II with either angiotensin converting enzyme inhibitors or AT 1 receptor antagonists reduces MAP in the SHR, regardless of age (reviewed in Ref. 16 ). Therefore, the effectiveness of NO in regulating TGF may well depend on the physiological state of the animal, which includes the level of oxidative stress and ANG II activity.
Previous studies have shown the importance of O 2 Ϫ in signaling ANG II actions in blood vessel wall (25) . ANG II concentrations probably are higher in the JGA than anywhere else in the body. The exaggerated TGF response of the SHR kidney is dependent on AT 1 receptors (6). Therefore, the JGA of the SHR should be a prominent site for ANG II-induced O 2 Ϫ generation. An overactive TGF mechanism would contribute to inappropriate preglomerular renal vasoconstriction and a limited capacity to excrete a salt load rapidly and effectively. As such, it may be an important pro-hypertensive mechanism. Indeed, Ollerstam et al. (23) have shown that inhibition of nNOS with 7-NI first increases TGF responsiveness and reduces renal function of normal rats. Later, 7-NI increases the blood pressure. The present studies have shown that one factor responsible for an exaggerated TGF response in SHR is overproduction of O 2 Ϫ leading to a functional state of NO deficiency. That this could contribute to maintenance of hypertension is shown by the normalization of renal vasoconstriction and hypertension by short-term infusion of tempol (31) and by the selective reduction in blood pressure in the SHR by 2 wk of oral tempol administration (30) .
